Revenue: The sum of all revenue fields included for a company's operating activities.
NRx Pharmaceuticals, Inc. (NRXP) had Revenue of $0.24M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$0.24M |
$-5.89M |
|
$0.10M |
|
$0.14M |
|
$4.27M |
|
$-4.02M |
|
$-1.87M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-5.89M |
|
$-4.02M |
|
$-4.02M |
|
22.23M |
|
22.23M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$11.95M |
|
$0.07M |
|
$3.05M |
|
$15.00M |
|
$40.59M |
|
-- |
|
$0.16M |
|
$40.75M |
|
$-25.75M |
|
$-28.14M |
|
$-25.75M |
|
27.68M |
|
| Cash Flow Statement Financials | |
$-10.40M |
|
$-2.56M |
|
$18.70M |
|
$1.44M |
|
$7.18M |
|
$5.74M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.29 |
|
-- |
|
-- |
|
-- |
|
-0.39 |
|
59.92% |
|
-1662.81% |
|
-1662.81% |
|
-- |
|
-2433.88% |
|
-2433.88% |
|
$-10.40M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
-- |
|
0.07 |
|
1236.94 |
|
22.87% |
|
20.93% |
|
-39.28% |
|
22.87% |
|
$-0.93 |
|
$-0.47 |
|
$-0.47 |
|